Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody

Author:

Cunha-Santos Catarina,Perdigao Pedro Ricardo Lucas,Martin Francisco,Oliveira Joana Gomes,Cardoso Miguel,Manuel Ana,Taveira Nuno,Goncalves Joao

Funder

Fundação para a Ciência e a Tecnologia

HIVERA

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Reference59 articles.

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806–811. http://www.ncbi.nlm.nih.gov/pubmed/9486653

2. Daka A, Peer D (2012) RNAi-based nanomedicines for targeted personalized therapy. Adv Drug Deliv Rev 64(13):1508–1521. https://doi.org/10.1016/j.addr.2012.08.014

3. Krebs MD, Alsberg E. Localized, targeted, and sustained siRNA delivery. Chemistry 17(11):3054–3062 (2011). http://www.ncbi.nlm.nih.gov/pubmed/21341332

4. Bobbin ML, Burnett JC, Rossi JJ (2015) RNA interference approaches for treatment of HIV-1 infection. Genome Med 7(1):50. http://genomemedicine.com/content/7/1/50

5. Spagnou S, Miller AD, Keller M (2004) Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43(42):13348–13356. http://www.ncbi.nlm.nih.gov/pubmed/15491141

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. CXCR4 Is a Potential Target for Anti-HIV Gene Therapy;International Journal of Molecular Sciences;2024-01-18

2. Single-domain antibodies applied as antiviral immunotherapeutics;Journal of Virological Methods;2023-10

3. Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs);Pharmaceuticals;2023-06-09

4. Discovery and design of G protein-coupled receptor targeting antibodies;Expert Opinion on Drug Discovery;2023-03-29

5. Nanobodies: A Review of Generation, Diagnostics and Therapeutics;International Journal of Molecular Sciences;2023-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3